Loading clinical trials...
Loading clinical trials...
Predictive Factors of the Treatment Failure in HCV Mono-infected Patients Treated With Pegylated-interferon/Ribavirin/Telaprevir.
Conditions
Locations
1
France
Hôpital du haut-Lévêque
Pessac, France
Start Date
February 1, 2011
Primary Completion Date
January 1, 2013
Completion Date
January 1, 2013
Last Updated
June 22, 2016
NCT00199719
NCT06922643
NCT03612973
NCT01866930
NCT05895448
NCT02219490
Lead Sponsor
Association HGE CHU Bordeaux Sud
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions